Statin use and mortality among ovarian cancer patients: A population-based cohort study

Keyphrases

• Population-based Cohort Study 100%
• Ovarian Cancer Patients 100%
• Statin Use 100%
• Ovarian Cancer 66%
• Confidence Interval 50%
• Hazard Ratio 50%
• Statins 50%
• Cancer Mortality 50%
• Post-diagnostic Support 50%
• Epithelial Ovarian Cancer 33%
• Reduced Mortality 33%
• Nationwide Registers 16%
• First Diagnosis 16%
• Confounding Factors 16%
• Dose-response Relationship 16%
• Danish Cancer Registry 16%
• Cox Proportional Hazards Regression Model 16%
• Mortality Hazard 16%
• Sensitivity Analysis 16%
• Cancer Patients 16%
• In Cancer 16%
• Low-dose Aspirin 16%
• Histological Subtypes 16%
• Tumor Histology 16%
• Endometrioid 16%
• New User 16%
• Clear Cell Tumor 16%
• Differential Susceptibility 16%

Medicine and Dentistry

• Cohort Analysis 100%
• Ovarian Cancer 100%
• Statin 100%
• Diagnosis 33%
• Hazard Ratio 33%
• Malignant Neoplasm 22%
• Krukenberg Tumor 22%
• Cancer Registry 11%
• Dose Response 11%
• Identified Patient 11%
• Acetylsalicylic Acid 11%
• Proportional Hazards Model 11%
• Low Drug Dose 11%
• Clear Cell Carcinoma 11%
• Tumor Histology 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Cohort Study 100%
• Ovary Cancer 100%
• Statin (Protein) 100%
• Malignant Neoplasm 28%
• Ovary Carcinoma 28%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 28%
• Dose-Response Relationship 14%
• Acetylsalicylic Acid 14%
• Clear Cell Carcinoma 14%
• Cancer Registry 14%